White matter injury contributes to neurological disorders after acute ischemic stroke (AIS). The repair of white matter injury is dependent on the re-myelination by oligodendrocytes. Both melatonin and serotonin antagonist have been proved to protect against post-stroke white matter injury. Agomelatine (AGM) is a multi-functional treatment which is both a melatonin receptor agonist and selective serotonin receptor antagonist. Whether AGM protects against white matter injury after stroke and the underlying mechanisms remain elusive. Here, using the transient middle cerebral artery occlusion (tMCAO) model, we evaluated the therapeutic effects of AGM in stroke mice. Sensorimotor and cognitive functions, white matter integrity, oligodendroglial regeneration and re-myelination in stroke hemisphere after AGM treatment were analyzed. We found that AGM efficiently preserved white matter integrity, reduced brain tissue loss, attenuated long-term sensorimotor and cognitive deficits in tMCAO models. AGM treatment promoted OPC differentiation and enhanced re-myelination both in vitro, ex vivo and in vivo, although OPC proliferation was unaffected. Mechanistically, AGM activated low density lipoprotein receptor related protein 1 (LRP1), peroxisome proliferator-activated receptor γ (PPARγ) signaling thus promoted OPC differentiation and re-myelination after stroke. Inhibition of PPARγ or knock-down of LRP1 in OPCs reversed the beneficial effects of AGM. Altogether, our data indicate that AGM represents a novel therapy against white matter injury after cerebral ischemia.
RenúAMillánMSan RománL, et al.
Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke: the CHOICE randomized clinical trial. JAMA2022;
327: 826–835.
2.
SainiVGuadaLYavagalDR.Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology2021;
97: S6–S16.
3.
BoltzeJAronowskiJABadautJ, et al.
New mechanistic insights, novel treatment paradigms, and clinical progress in cerebrovascular diseases. Front Aging Neurosci2021;
13: 623751.
4.
StadelmannCTimmlerSBarrantes-FreerA, et al.
Myelin in the central nervous system: structure, function, and pathology. Physiol Rev2019;
99: 1381–1431.
5.
ZhangQZhuWXuF, et al.
The interleukin-4/PPARγ signaling axis promotes oligodendrocyte differentiation and remyelination after brain injury. PLOS Biol2019;
17: e3000330.
6.
FranklinRJMFfrench-ConstantC.Regenerating CNS myelin – from mechanisms to experimental medicines. Nat Rev Neurosci2017;
18: 753–769.
7.
ZhouYZhangJWangL, et al.
Interleukin-1β impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion. Brain Behav Immun2017;
60: 93–105.
8.
SozmenEGRosenzweigSLlorenteIL, et al.
Nogo receptor blockade overcomes remyelination failure after white matter stroke and stimulates functional recovery in aged mice. Proc Natl Acad Sci USA2016;
113: E8453–E8462.
9.
ZhaoYZhuWWanT, et al.
Vascular endothelium deploys caveolin-1 to regulate oligodendrogenesis after chronic cerebral ischemia in mice. Nat Commun2022;
13: 6813.
10.
DaiXChenJXuF, et al.
TGFα preserves oligodendrocyte lineage cells and improves white matter integrity after cerebral ischemia. J Cereb Blood Flow Metab2020;
40: 639–655.
11.
KremerDGöttlePHartungH-P, et al.
Pushing forward: remyelination as the new frontier in CNS diseases. Trends Neurosci2016;
39: 246–263.
12.
HuangJLiZHuY, et al.
Melatonin, an endogenous hormone, modulates Th17 cells via the reactive-oxygen species/TXNIP/HIF-1α axis to alleviate autoimmune uveitis. J Neuroinflamm2022;
19: 124.
13.
QuintelaTGonçalvesISilvaM, et al.
Choroid plexus is an additional source of melatonin in the brain. J Pineal Res2018;
65: e12528.
14.
LiDHeTZhangY, et al.
Melatonin regulates microglial polarization and protects against ischemic stroke-induced brain injury in mice. Exp Neurol2023;
367: 114464.
15.
FengDWangBWangL, et al.
Pre-ischemia melatonin treatment alleviated acute neuronal injury after ischemic stroke by inhibiting endoplasmic reticulum stress-dependent autophagy via PERK and IRE1 signalings. J Pineal Res2017;
62: e12395.
16.
LiuZ-JRanY-YQieS-Y, et al.
Melatonin protects against ischemic stroke by modulating microglia/macrophage polarization toward anti-inflammatory phenotype through STAT3 pathway. CNS Neurosci Ther2019;
25: 1353–1362.
17.
ChenBHParkJHLeeYL, et al.
Melatonin improves vascular cognitive impairment induced by ischemic stroke by remyelination via activation of ERK1/2 signaling and restoration of glutamatergic synapses in the gerbil hippocampus. Biomedicine & Pharmacotherapy2018;
108: 687–697.
18.
LuDLiuYHuangH, et al.
Melatonin offers dual-phase protection to brain vessel endothelial cells in prolonged cerebral ischemia-recanalization through ameliorating ER stress and resolving refractory stress granule. Transl Stroke Res2022;
14: 910–928.
19.
FanL-WBhattATienL-T, et al.
Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro. J Neurochem2015;
133: 532–543.
20.
CholletFRigalJMarqueP, et al.
Serotonin selective reuptake inhibitors (SSRIs) and stroke. Curr Neurol Neurosci Rep2018;
18: 100.
21.
NormanTROlverJS.Agomelatine for depression: expanding the horizons?Expert Opin Pharmacother2019;
20: 647–656.
22.
LinJ-PMironovaYAShragerP, et al.
LRP1 regulates peroxisome biogenesis and cholesterol homeostasis in oligodendrocytes and is required for proper CNS myelin development and repair. eLife2017;
6: e30498.
23.
PuHZhengXJiangX, et al.
Interleukin-4 improves white matter integrity and functional recovery after murine traumatic brain injury via oligodendroglial PPARγ. J Cereb Blood Flow Metab2021;
41: 511–529.
24.
ChenYBalasubramaniyanVPengJ, et al.
Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc2007;
2: 1044–1051.
25.
HanLCaiWMaoL, et al.
Rosiglitazone promotes white matter integrity and long-term functional recovery after focal cerebral ischemia. Stroke2015;
46: 2628–2636.
26.
LeeSLeachMKRedmondSA, et al.
A culture system to study oligodendrocyte myelination processes using engineered nanofibers. Nat Methods2012;
9: 917–922.
27.
BarateiroAFernandesA.Temporal oligodendrocyte lineage progression: in vitro models of proliferation, differentiation and myelination. Biochim Biophys Acta2014;
1843: 1917–1929.
28.
HumpelC.Organotypic brain slice cultures: a review. Neuroscience2015;
305: 86–98.
BourinMMocaërEPorsoltR.Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. Journal of Psychiatry and Neuroscience2004;
29: 126–133.
31.
CaoYWangFWangY, et al.
Agomelatine prevents macrophage infiltration and brain endothelial cell damage in a stroke mouse model. Aging (Albany NY)2021;
13: 13548–13559.
32.
El YacoubiMDuboisMGabrielC, et al.
Chronic agomelatine and fluoxetine induce antidepressant-like effects in H/rouen mice, a genetic mouse model of depression. Pharmacology Biochemistry and Behavior2011;
100: 284–288.
33.
RainerQXiaLGuillouxJ-P, et al.
Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. Int J Neuropsychopharmacol2012;
15: 321–335.
34.
BhutadaPDixitPThakurK, et al.
Effects of agomelatine in a murine model of obsessive–compulsive disorder: interaction with meta-chlorophenylpiperazine, bicuculline, and diazepam. Kaohsiung J Med Sci2013;
29: 362–367.
35.
TuranNMillerBAHeiderRA, et al.
Neurobehavioral testing in subarachnoid hemorrhage: a review of methods and current findings in rodents. J Cereb Blood Flow Metab2017;
37: 3461–3474.
36.
RuanJYaoY.Behavioral tests in rodent models of stroke. Brain Hemorrhages2020;
1: 171–184.
37.
ShiXBaiHHuangL, et al.
Behavioral assessment of sensory, motor, emotion, and cognition in rodent models of intracerebral hemorrhage. Front Neurol June 2021;
12: 667511.
38.
WangJJiangCZhangK, et al.
Melatonin receptor activation provides cerebral protection after traumatic brain injury by mitigating oxidative stress and inflammation via the Nrf2 signaling pathway. Free Radic Biol Med2019;
131: 345–355.
39.
LiuXLiuJZhaoS, et al.
Interleukin-4 is essential for microglia/macrophage M2 polarization and long-term recovery after cerebral ischemia. Stroke2016;
47: 498–504.
40.
VorheesCVWilliamsMT.Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc2006;
1: 848–858.
41.
JiaPWangJRenX, et al.
An enriched environment improves long-term functional outcomes in mice after intracerebral hemorrhage by mechanisms that involve the Nrf2/BDNF/glutaminase pathway. J Cereb Blood Flow Metab2023;
43: 694–711.
42.
BellBJMalvankarMMTallonC, et al.
Sowing the seeds of discovery: tau-propagation models of Alzheimer’s disease. ACS Chem Neurosci2020;
11: 3499–3509.
43.
LiL-BFanY-GWuW-X, et al.
Novel melatonin-trientine conjugate as potential therapeutic agents for Alzheimer’s disease. Bioorg Chem2022;
128: 106100.
44.
MaoHLockyerPLiL, et al.
Endothelial LRP1 regulates metabolic responses by acting as a co-activator of PPARγ. Nat Commun2017;
8: 14960.
45.
HanBJiangWCuiP, et al.
Microglial PGC-1α protects against ischemic brain injury by suppressing neuroinflammation. Genome Med2021;
13: 47.
46.
ChumboatongWKhamchaiSTocharusC, et al.
Agomelatine exerts an anti-inflammatory effect by inhibiting microglial activation through TLR4/NLRP3 pathway in pMCAO rats. Neurotox Res2022;
40: 259–266.
47.
ChumboatongWKhamchaiSTocharusC, et al.
Agomelatine protects against permanent cerebral ischaemia via the Nrf2-HO-1 pathway. Eur J Pharmacol2020;
874: 173028.
48.
Fernández-CastañedaAChappellMSRosenDA, et al.
The active contribution of OPCs to neuroinflammation is mediated by LRP1. Acta Neuropathol2020;
139: 365–382.
49.
TowfighiASaverJLEngelhardtR, et al.
A midlife stroke surge among women in the United States. Neurology2007;
69: 1898–1904.
50.
LiuFYuanRBenashskiSE, et al.
Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab2009;
29: 792–802.
51.
FeiginVLBraininMNorrvingB, et al.
World stroke organization (WSO): global stroke fact sheet 2022. Int J Stroke2022;
17: 18–29.
52.
CaiWZhangKLiP, et al.
Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: an aging effect. Ageing Res Rev2017;
34: 77–87.
53.
BadanIBuchholdBHammA, et al.
Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery. J Cereb Blood Flow Metab2003;
23: 845–854.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
